AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

June 5-6

Boston, MA

Boston Harbor Hotel

70 Rowes Wharf

Boston, MA 02110

+1 (617) 439-7000

AGENDA

  • Review of AQC workstreams:
    • Site Centricity
    • Inspection Readiness
    • Prequalification
    • Risk Management
  • Hands-on, deep-dive workshops:
    • Quality Tolerance Limits – Unraveling the mystery of QTLs.
    • Risk-based Inspection Readiness – Utilizing dashboarding and metrics to track inspection readiness real-time.
    • Enhancing Site Quality – Enabling site feedback at study design and other implementable ways to increase quality and compliance at investigative sites.
    • De-mystifying Decentralized Trial Qualification – Avoca’s work in prequalification helps the industry qualify technology providers who are assisting in capturing data for traditional or decentralized clinical trials. Learn how to qualify vendors in the current climate of uncertainty in regulatory requirement interpretation.
  • Discussion on how clinical trials are changing in light of new technologies and what we can look forward to as an industry. Discussion will include digitizing clinical trials using wearables, best practices, and perspectives on what is required of sponsors.
  • Panel discussion on risk management and mitigation as new wave of technologies are developed to support clinical trial execution.
  • Plenty of time for networking and collaborating with other attendees.
  • Panel discussion on clinical research merging with patient care and how technology impacts the patient experience. Panelists will discuss how the industry’s role in patient engagement can evolve as the approach to clinical trials evolves.
  • Discussion on the future of clinical research as a care option.
  • Patient engagement activities that will be necessary to ensure the survival of an industry that relies on volunteers.
  • The Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with The Avoca Group, have established a working group to benchmark the vendor qualification assessment process and identify improvement opportunities. Preliminary insights of the study will be discussed.